AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6873004 — intervention group
Group type: EXPERIMENTAL
Intervention: Social alcohol intake (1-3 glasses of vodka mixed with orangeade, consumed twice a week for 16 weeks)
Number of subjects: 0
Study 6873004 — intervention group
Group type: EXPERIMENTAL
Intervention: Social alcohol intake
Number of subjects: 0
Study 31745051 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II - purple-coated TMA archwires
Number of subjects: 63
Study 31745051 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III - honey dew-coated TMA wires
Number of subjects: 63
Study 31745051 — intervention group
Group type: COMPARATOR
Intervention: Group I - regular TMA archwires
Number of subjects: 63
Study 29725798 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy group
Number of subjects: 39
Study 29725798 — intervention group
Group type: COMPARATOR
Intervention: Exercise group
Number of subjects: 39
Study 26937930 — intervention group
Group type: EXPERIMENTAL
Intervention: Foraminoplasty via upper border of inferior pedicle (Group A)
Number of subjects: 45
Study 26937930 — intervention group
Group type: COMPARATOR
Intervention: Common transforaminal route (Group B)
Number of subjects: 45
Study 24719139 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN/D5600 (alendronate 70 mg + 5600 IU vitamin D₃)
Number of subjects: 268
Study 24719139 — intervention group
Group type: COMPARATOR
Intervention: ALN (alendronate 70 mg without additional vitamin D)
Number of subjects: 268
Study 24719139 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN/D5600
Number of subjects: 268
Study 24719139 — intervention group
Group type: COMPARATOR
Intervention: ALN
Number of subjects: 268
Study 24719139 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN/D5600 and ALN
Number of subjects: 268
Study 23767196 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (100 microgram stat) along with fluid and antibiotics
Number of subjects: 150
Study 23767196 — intervention group
Group type: EXPERIMENTAL
Intervention: Racecadotril (1.5 mg/kg three times a day) along with fluid and antibiotics
Number of subjects: 150
Study 23767196 — intervention group
Group type: COMPARATOR
Intervention: Control group received only fluids and antibiotics
Number of subjects: 150
Study 19395036 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative diagnosis of pseudophakic or aphakic corneal edema
Number of subjects: 1090
Study 19395036 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior glaucoma surgery with preoperative glaucoma medication use
Number of subjects: 1090
Study 19395036 — intervention group
Group type: COMPARATOR
Intervention: Age, gender, diabetes, smoking, and graft size
Number of subjects: 1090
Study 17848840 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) with aspart or lispro insulin
Number of subjects: 36
Study 17848840 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections (MDI) with once-daily glargine and human regular insulin at meals
Number of subjects: 36
Study 15854937 — intervention group
Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 120
Study 15854937 — intervention group
Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 120
Study 15854937 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 11952586 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation (group 2)
Number of subjects: 28
Study 11952586 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (group 1)
Number of subjects: 28
Study 9862252 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 25 mg capsules (two capsules after a 10 h fast)
Number of subjects: 48
Study 7650233 — intervention group
Group type: EXPERIMENTAL
Intervention: Td vaccine alone (group 1)
Number of subjects: 119
Study 7650233 — intervention group
Group type: COMPARATOR
Intervention: Td vaccine plus 500 IU of TIG (group 2)
Number of subjects: 119
Study 2792781 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (12-week, 36 classes)
Number of subjects: 50
Study 2792781 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 805518 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified maize
Number of subjects: 0
Study 805518 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified rice
Number of subjects: 0
Study 805518 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified bread
Number of subjects: 0
Study 805518 — intervention group
Group type: COMPARATOR
Intervention: Aqueous solution of pteroylglutamic acid
Number of subjects: 0
Study 31758324 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (n = 92)
Number of subjects: 180
Study 31758324 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 88)
Number of subjects: 180
Study 31184639 — intervention group
Group type: EXPERIMENTAL
Intervention: Milled bar overdentures
Number of subjects: 36
Study 31184639 — intervention group
Group type: COMPARATOR
Intervention: Ceramo-metal fixed prostheses
Number of subjects: 36
Study 31184639 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (milled bar overdentures and fixed prostheses)
Number of subjects: 36
Study 31184639 — intervention group
Group type: COMPARATOR
Intervention: Fixed prostheses
Number of subjects: 36
Study 28709650 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin-warfarin
Number of subjects: 2199
Study 25956739 — intervention group
Group type: EXPERIMENTAL
Intervention: Unlinked, modular bicompartmental arthroplasty (BCA)
Number of subjects: 48
Study 25956739 — intervention group
Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 48
Study 22672107 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg daily)
Number of subjects: 20
Study 22672107 — intervention group
Group type: COMPARATOR
Intervention: Control group (Aspirin 100 mg or Clopidogrel 50 mg‐75 mg daily)
Number of subjects: 20
Study 21663422 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium 300 mg twice daily (Arm I)
Number of subjects: 61
Study 21663422 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium 300 mg thrice daily (Arms II and III)
Number of subjects: 61
Study 21663422 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (all arms)
Number of subjects: 61
Study 20178287 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate feedback
Number of subjects: 63
Study 20178287 — intervention group
Group type: COMPARATOR
Intervention: False feedback
Number of subjects: 63
Study 16965240 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 122
Study 16965240 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat (15% of energy)
Number of subjects: 122
Study 16965240 — intervention group
Group type: EXPERIMENTAL
Intervention: High fruit and vegetable (9 servings per day)
Number of subjects: 122
Study 16965240 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination low fat, high FV
Number of subjects: 122
Study 15861964 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation and shoulder exercises program according to Bobath
Number of subjects: 20
Study 15861964 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation only
Number of subjects: 20
Study 11151749 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg twice daily for 7 days
Number of subjects: 7
Study 11151749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 9291904 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 1160
Study 9291904 — intervention group
Group type: COMPARATOR
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 1160
Study 8378121 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 84
Study 8378121 — intervention group
Group type: COMPARATOR
Intervention: Nylidrin
Number of subjects: 84
Study 3704451 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (10, 30, or 60 mg/day)
Number of subjects: 17
Study 3704451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemoline (18.75, 56.25, or 112.5 mg/day)
Number of subjects: 17
Study 3704451 — intervention group
Group type: EXPERIMENTAL
Intervention: Protriptyline (10, 30, or 60 mg/day)
Number of subjects: 17
Study 3704451 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 17
Study 28832089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleft lip and palate patients (study group)
Number of subjects: 54
Study 28832089 — intervention group
Group type: COMPARATOR
Intervention: General population patients (control group)
Number of subjects: 54
Study 27453375 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management intervention through a randomized clinical trial (RCT)
Number of subjects: 0
Study 27453375 — intervention group
Group type: COMPARATOR
Intervention: Reasons for declining referral
Number of subjects: 0
Study 25005346 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Tc-99m-tetrofosmin tracer dose
Number of subjects: 125
Study 25005346 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight-dependent tracer dose and scan time
Number of subjects: 125
Study 21495052 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral family therapy (BFT) plus fluoxetine
Number of subjects: 160
Study 21495052 — intervention group
Group type: COMPARATOR
Intervention: Behavioral family therapy (BFT) plus placebo
Number of subjects: 160
Study 21495052 — intervention group
Group type: EXPERIMENTAL
Intervention: Systems family therapy (SFT) plus fluoxetine
Number of subjects: 160
Study 21495052 — intervention group
Group type: COMPARATOR
Intervention: Systems family therapy (SFT) plus placebo
Number of subjects: 160
Study 20362843 — intervention group
Group type: EXPERIMENTAL
Intervention: View-in test
Number of subjects: 78
Study 20362843 — intervention group
Group type: COMPARATOR
Intervention: Wall-chart test
Number of subjects: 78
Study 20362843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract patients preoperative
Number of subjects: 78
Study 20362843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract patients postoperative
Number of subjects: 78
Study 18978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 10 mg
Number of subjects: 100
Study 18978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 5 mg
Number of subjects: 100
Study 16024863 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 Gy external beam radiotherapy (EBRT) delivered as 6 x 2 Gy fractions to the macula of an affected eye
Number of subjects: 199
Study 16024863 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 199
Study 12070572 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 2940
Study 12070572 — intervention group
Group type: COMPARATOR
Intervention: Control (any other anti-hypertensive)
Number of subjects: 2940
Study 10336033 — intervention group
Group type: EXPERIMENTAL
Intervention: PRK
Number of subjects: 31
Study 10336033 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 31
Study 10336033 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRS
Number of subjects: 31
Study 8984147 — intervention group
Group type: EXPERIMENTAL
Intervention: Troxerutin 3,500 mg
Number of subjects: 9
Study 8984147 — intervention group
Group type: EXPERIMENTAL
Intervention: Troxerutin 1,000 mg twice daily
Number of subjects: 9
Study 8984147 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 9
Study 1837496 — intervention group
Group type: COMPARATOR
Intervention: Acute verapamil administration (160 mg)
Number of subjects: 12
Study 1837496 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic verapamil treatment (240 mg/day for 12 months)
Number of subjects: 12
Study 6122652 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg flunitrazepam orally the night before operation and 1 mg on the morning of operation (group 1)
Number of subjects: 41
Study 6122652 — intervention group
Group type: COMPARATOR
Intervention: 100 mg pentobarbital orally the night before operation, followed by intramuscular scopolamine (0.006 mg/kg) + morphine (0.02 mg/kg) on the morning of operation (group 2)
Number of subjects: 41
Study 30979659 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut consumption (2 oz per day)
Number of subjects: 10
Study 30979659 — intervention group
Group type: COMPARATOR
Intervention: Control group (no walnut consumption)
Number of subjects: 10
Study 28844361 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive therapy
Number of subjects: 200
Study 28844361 — intervention group
Group type: COMPARATOR
Intervention: Counseling as standard care
Number of subjects: 200
Study 25543999 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic high velocity low amplitude thrust manipulations (HVLATM) to the thoracic spine
Number of subjects: 43
Study 22534819 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 33
Study 22534819 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sugar pill)
Number of subjects: 33
Study 21371164 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulated Collagen Gel (FCG)
Number of subjects: 124
Study 21371164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5PDGF‐B (GAM501)
Number of subjects: 124
Study 21371164 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 124
Study 19835120 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal moxa stick moxibustion (MMS)
Number of subjects: 144
Study 19835120 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxa stick moxibustion (MS)
Number of subjects: 144
Study 19835120 — intervention group
Group type: COMPARATOR
Intervention: Nitramisole cream (NC)
Number of subjects: 144
Study 17907004 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized estradiol 2 mg/day
Number of subjects: 86
Study 17907004 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized estradiol 2 mg/day plus norethisterone acetate 1 mg/day
Number of subjects: 86
Study 17907004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 15860489 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 100
Study 15860489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 12040360 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbogrel (thromboxane synthetase inhibitor and receptor antagonist) for 12 weeks
Number of subjects: 71
Study 12040360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 9873846 — intervention group
Group type: EXPERIMENTAL
Intervention: Asserachrom VIII:CAg ELISA using monoclonal antibodies (MoAbs 833 and D4H1)
Number of subjects: 294
Study 9873846 — intervention group
Group type: EXPERIMENTAL
Intervention: Asserachrom VIII:CAg ELISA
Number of subjects: 294
Study 8848535 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (1.2 mg)
Number of subjects: 54
Study 8848535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 2365604 — intervention group
Group type: EXPERIMENTAL
Intervention: Education (E) alone consisting of a brief lecture on AIDS
Number of subjects: 75
Study 2365604 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced education (EE) with a lecture and videotape on condom use
Number of subjects: 75
Study 2365604 — intervention group
Group type: COMPARATOR
Intervention: Controls (C) receiving no education
Number of subjects: 75
Study 688767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultramicrosize griseofulvin (Gris-PEG)
Number of subjects: 73
Study 688767 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clotrimazole (Lotrimin)
Number of subjects: 73
Study 688767 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ultramicrosize griseofulvin and topical clotrimazole
Number of subjects: 73
Study 30314724 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral lymph node dissection
Number of subjects: 445
Study 30314724 — intervention group
Group type: COMPARATOR
Intervention: Non-lateral lymph node dissection
Number of subjects: 445
Study 28694345 — intervention group
Group type: EXPERIMENTAL
Intervention: Link online mental health help-seeking navigation tool
Number of subjects: 51
Study 28694345 — intervention group
Group type: COMPARATOR
Intervention: Usual help-seeking strategies with a link to Google.com
Number of subjects: 51
Study 25994853 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib administered 2 hours after a meal
Number of subjects: 23
Study 25994853 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib administered in complete fasting
Number of subjects: 23
Study 24152604 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin under fasted conditions
Number of subjects: 18
Study 24152604 — intervention group
Group type: COMPARATOR
Intervention: 25 mg empagliflozin after a high‐fat, high‐calorie breakfast
Number of subjects: 18
Study 24152604 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg empagliflozin under fasted conditions
Number of subjects: 18
Study 21781598 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted minimally invasive radiofrequency ablation (MIA)
Number of subjects: 172
Study 21781598 — intervention group
Group type: COMPARATOR
Intervention: Catheter ablation (CA)
Number of subjects: 172
Study 19641522 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD flow
Number of subjects: 69
Study 19641522 — intervention group
Group type: EXPERIMENTAL
Intervention: RQ-PCR
Number of subjects: 69
Study 19641522 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD flow and PCR
Number of subjects: 69
Study 19641522 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR
Number of subjects: 69
Study 17848854 — intervention group
Group type: EXPERIMENTAL
Intervention: $7 financial incentive
Number of subjects: 0
Study 17848854 — intervention group
Group type: EXPERIMENTAL
Intervention: $14 financial incentive
Number of subjects: 0
Study 17848854 — intervention group
Group type: COMPARATOR
Intervention: No financial incentive
Number of subjects: 0
Study 17848854 — intervention group
Group type: EXPERIMENTAL
Intervention: Equalized financial gains across groups
Number of subjects: 0
Study 14969628 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon-coated stents (CC)
Number of subjects: 347
Study 14969628 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel stents (SS)
Number of subjects: 347
Study 11355930 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage (GM)-CSF or Granulocyte (G)-CSF
Number of subjects: 0
Study 11355930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokines (CSFs)
Number of subjects: 0
Study 11355930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokines (e.g. pegylated recombinant human megakaryocytic growth and development factor + G- or GM-CSF)
Number of subjects: 0
Study 11355930 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies targeting cytokine receptors on AML blasts
Number of subjects: 0
Study 9153103 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO administration (120 U/kg per week for 5 to 8 months)
Number of subjects: 50
Study 9153103 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EPO treatment)
Number of subjects: 50
Study 7899040 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal shearing motion with lateral head movement
Number of subjects: 0
Study 7899040 — intervention group
Group type: COMPARATOR
Intervention: Stimulus producing MAE
Number of subjects: 0
Study 3584749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated IgG (10 to 15 gm)
Number of subjects: 27
Study 3584749 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 27
Study 3584749 — intervention group
Group type: EXPERIMENTAL
Intervention: Active immunization with HBV
Number of subjects: 27
Study 29673375 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Potential® service (PHC)
Number of subjects: 0
Study 29673375 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional lifestyle counselling (part B)
Number of subjects: 0
Study 29673375 — intervention group
Group type: COMPARATOR
Intervention: General health check (GHC)
Number of subjects: 0
Study 28778814 — intervention group
Group type: EXPERIMENTAL
Intervention: Education about exercise-induced hypoalgesia (EIH)
Number of subjects: 40
Study 28778814 — intervention group
Group type: COMPARATOR
Intervention: General education about exercise and pain (Control)
Number of subjects: 40
Study 26222158 — intervention group
Group type: EXPERIMENTAL
Intervention: Channa striatus extract (500 mg daily for six weeks)
Number of subjects: 66
Study 26222158 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mg maltodextrin daily for six weeks)
Number of subjects: 66
Study 23876947 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA appliance
Number of subjects: 44
Study 23876947 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no treatment)
Number of subjects: 44
Study 21967936 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion and facemask therapy
Number of subjects: 22
Study 21967936 — intervention group
Group type: COMPARATOR
Intervention: Control groups with untreated Class III malocclusion
Number of subjects: 22
Study 18928090 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint thread embedding (ATE) at Shenmen (HT7), Fenglong (ST40), Taixi (KI3), and Zusanli (ST36) acupoints, once every month for 6 times in total.
Number of subjects: 26
Study 18928090 — intervention group
Group type: COMPARATOR
Intervention: Sham operation at the same acupoints.
Number of subjects: 26
Study 16646643 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene protocol managed by a dental hygienist
Number of subjects: 82
Study 16646643 — intervention group
Group type: COMPARATOR
Intervention: No assistance from dental hygienist (control group)
Number of subjects: 82
Study 14608343 — intervention group
Group type: EXPERIMENTAL
Intervention: lincomycin
Number of subjects: 78
Study 14608343 — intervention group
Group type: EXPERIMENTAL
Intervention: rondomycin
Number of subjects: 78
Study 14608343 — intervention group
Group type: COMPARATOR
Intervention: no decontamination therapy
Number of subjects: 78
Study 11097587 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine Eye Drops (0.05%)
Number of subjects: 80
Study 11097587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 8922008 — intervention group
Group type: COMPARATOR
Intervention: Intermittent nebulized (IN) albuterol (0.15 mg/kg/dose every 30 min)
Number of subjects: 70